CHMP’s September 2023 meeting highlights
In its September 2023 meeting, the EMA’s human medicines committee (CHMP) recommended nine medicines for approval and the extension of therapeutic indications for 11 medicines.
List view / Grid view
In its September 2023 meeting, the EMA’s human medicines committee (CHMP) recommended nine medicines for approval and the extension of therapeutic indications for 11 medicines.
The EMA CHMP has given a positive opinion for marketing authorisation approval to seven medicines following its October meeting.
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.